The role of a novel MYB > (ATR-ATM-BUB1) axis in adenoid cystic carcinoma: therapeutic implications
Funder: Oracle Cancer TrustDuration: September 2019 - August 2022
People
| Name | Telephone | Office | ||
|---|---|---|---|---|
|
Professor Arturo Sala Professor (Principal investigator)
T: +44 (0)1895 265547
E: arturo.sala@brunel.ac.uk |
+44 (0)1895 265547 | arturo.sala@brunel.ac.uk | Heinz Wolff 123A |
Outputs
Cicirò, Y., Ragusa, D., Tejera Nevado, P., Lattanzio, R., Sala, G., DesRochers, T., et al. (2023) 'The mitotic checkpoint kinase BUB1 is a direct and actionable target of MYB in adenoid cystic carcinoma'. FEBS Letters, 598 (2). pp. 252 - 265. ISSN: 0014-5793
Cicirò, Y. and Sala, A. (2021) 'MYB oncoproteins: emerging players and potential therapeutic targets in human cancer'. Oncogenesis, 10 (2). pp. 1 - 15. ISSN: 2157-9024